Abstract
Purpose:Microbeam radiation therapy is an innovative treatment approach in radiation therapy that uses arrays of a few tens of micrometer wide and a few hundreds of micrometer spaced planar x‐ray beams as treatment fields. In preclinical studies these fields efficiently eradicated tumors while normal tissue could effectively be spared. However, development and clinical application of microbeam radiation therapy is impeded by a lack of suitable small scale sources. Until now, only large synchrotrons provide appropriate beam properties for the production of microbeams.Methods:In this work, a conventional x‐ray tube with a small focal spot and a specially designed collimator are used to produce microbeams for preclinical research. The applicability of the developed source is demonstrated in a pilot in vitro experiment. The properties of the produced radiation field are characterized by radiochromic film dosimetry.Results:50 μm wide and 400 μm spaced microbeams were produced in a 20 × 20 mm2 sized microbeam field. The peak to valley dose ratio ranged from 15.5 to 30, which is comparable to values obtained at synchrotrons. A dose rate of up to 300 mGy/s was achieved in the microbeam peaks. Analysis of DNA double strand repair and cell cycle distribution after in vitro exposures of pancreatic cancer cells (Panc1) at the x‐ray tube and the European Synchrotron leads to similar results. In particular, a reduced G2 cell cycle arrest is observed in cells in the microbeam peak region.Conclusions:At its current stage, the source is restricted to in vitro applications. However, moderate modifications of the setup may soon allow in vivo research in mice and rats.
Highlights
In radiotherapy, as in any other cancer treatment, the aim is to maximize its lethal effect to the tumor tissue while reducing side effects to surrounding healthy tissue as much as possible
In order to achieve more than 95% of the maximum dose rate, the horizontal position needs to be adjusted with ±100 μm and the vertical position with ±1.5 mm accuracy
The highest output is achieved within 1 mm accuracy of the 70 mm focal spot to collimator distance used for the design of the collimator
Summary
As in any other cancer treatment, the aim is to maximize its lethal effect to the tumor tissue while reducing side effects to surrounding healthy tissue as much as possible. This aim is achieved by geometrically concentrating lethal dose levels in the tumor and exposing organs at risk below the tissue tolerance. Manifold evidence indicates that blood vessels and their different repair efficiencies in malignant and healthy tissue are essential to explain the differential effect of microbeams.[2,4,5,13] Apart from that experiments demonstrate that bystander signals,[14,15] changes in the immune response, DNA repair, and variations in the cell cycle[16] are important for the biological response to MRT
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
